Highlights the risk of acute arterial thrombosis during Adriamycin-cyclophosphamide chemotherapy in breast cancer patients, requiring immediate anticoagulant and surgical intervention.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to arterial thrombosis risk with AC chemotherapy; hypothesis-generating case report requiring prospective validation.
Despite the low risks of arterial thrombosis in breast cancer, it is a devastating complication with significant morbidity and mortality. Thromboprophylaxis should be considered in those at risk. Immediate anticoagulant therapy and surgical intervention should be considered in affected cases.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: